联合中医证型分析喉癌变的影响因素及构建预测模型

doi:10.6040/j.issn.1673-3770.0.2024.356

摘要/Abstract

摘要： 目的联合中医证型分析喉癌变的影响因素并建立列线图预测模型。方法回顾性收集首次确诊为早期喉癌、癌前病变的219例患者的临床资料作为病例组,选取同期125例声带息肉患者作为对照组。通过Logistic回归分析筛选喉癌变的独立危险因素,联合独立危险因素构建列线图预测模型,采用受试者工作特征曲线(receivering operating characteristic, ROC)、ROC曲线下面积(the area under the ROC curve, AUC)、一致性指数(the consistency index, C -index)进行评价,模型的校准度通过Hosmer-Lemeshow Test和校准曲线图评价。结果多因素回归分析显示高龄、男性人群、吸烟、饮酒、证型为气血凝结证、白细胞(white blood cells, WBC)、中性粒细胞/淋巴比值细胞(neutrophil to lymphocyte ratio, NLR)升高为患者罹患喉癌变的独立危险因素,差异有统计学意义(P<0.05),基于上述7个独立危险因素构建列线图模型;ROC曲线评估模型区分度结果显示,联合预测AUC为0.923(95%CI:0.895~0.952)(P<0.01),灵敏度为83.6%,特异度为87.2%;Hosmer-Lemeshow Test显示,列线图的拟合优度良好(χ2=8.853,P=0.355);模型的校准曲线显示,模型的区分度良好(平均绝对误差=0.009, C-index=0.923)。结论高龄、男性人群、吸烟、饮酒、证型为气血凝结证、WBC、NLR是喉癌变的独立危险因素,建立的中西医结合的列线图预测模型能有效预测发生喉癌变的风险,为临床早期防治喉癌变提供一定的参考。

关键词: 喉癌, 癌前病变, 喉癌变, 列线图模型, 预测

Abstract: Objective To analyze the influencing factors of laryngeal carcinogenesis, incorporating traditional Chinese medicine(TCM)syndrome patterns, and to develop a nomogram prediction model. Methods The clinical data of 219 patients who were first diagnosed with early laryngeal cancer and precancerous lesions in the Department of Otorhinolaryngology of Zhongshan Hospital of Traditional Chinese Medicine from January 2013 to December 2023 were collected retrospectively as the case group, and 125 patients with vocal cord polyps during the same period were selected as the control group. Independent risk factors for laryngeal carcinogenesis were identified using Logistic regression analysis. A nomogram was constructed based on these factors. The model's discrimination was evaluated using the receiver operating characteristic(ROC)curve, the area under the curve(AUC), and the Concordance Index(C-index). The model's calibration was assessed using the Hosmer-Lemeshow test and a calibration curve. Results Multivariate regression analysis showed that advanced age, male sex, smoking, alcohol consumption, Qi stagnation and blood stasis syndrome, elevated WBC, and elevated NLR were significant independent risk factors for laryngeal carcinogenesis(all P<0.05). A nomogram was constructed based on these seven factors. The area under the ROC curve(AUC)for the combined model was 0.923(95% CI: 0.895-0.952), with a sensitivity of 83.6% and a specificity of 87.2%. The Hosmer-Lemeshow test indicated good goodness-of-fit for the nomogram(χ2=8.853, P=0.355). The calibration curve demonstrated good agreement(mean absolute error=0.009), and the model showed excellent discrimination(C-index=0.923). Conclusion Advanced age, male sex, smoking, alcohol consumption, Qi stagnation and blood stasis syndrome, elevated WBC, and elevated NLR are independent risk factors for laryngeal carcinogenesis. The established nomogram, which integrates factors from both TCM and Western medicine, can effectively predict the risk of laryngeal carcinogenesis, providing a valuable reference for its early prevention and clinical management.

Key words: Laryngeal carcinoma, Precancerous lesion, Laryngeal carcinogenesis, Nomogram model, Prediction

中图分类号:

R739.65

章娜娜,黄冠江,卢标清. 联合中医证型分析喉癌变的影响因素及构建预测模型[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 29-37.

ZHANG Nana, HUANG Guanjiang, LU Biaoqing. Analysis of influencing factors for laryngeal carcinogenesis and construction of a predictive model[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 29-37.

参考文献 31

[1]	Yang YN, Li L, Zheng YZ, et al. A prospective, single-arm, phase II clinical trial of intraoperative radiotherapy using a low-energy X-ray source for local advanced Laryngocarcinoma(ILAL): a study protocol[J]. BMC Cancer, 2020, 20(1): 734. doi:10.1186/s12885-020-07233-1
[2]	Liberale C, Soloperto D, Marchioni A, et al. Updates on larynx cancer: risk factors and oncogenesis[J]. Int J Mol Sci, 2023, 24(16): 12913. doi:10.3390/ijms241612913
[3]	李慧, 孙安池, 张瑞静, 等. 窄带成像技术在诊断早期喉癌及癌前病变中的应用研究[J]. 中国耳鼻咽喉头颈外科, 2022, 29(11): 684-687. doi:10.16066/j.1672-7002.2022.11.002 LI Hui, SUN Anchi, ZHANG Ruijing, et al. Application of endoscopic narrow band imaging in the diagnosis of early laryngeal cancer and the precancerous lesions[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2022, 29(11): 684-687. doi:10.16066/j.1672-7002.2022.11.002
[4]	Chamoli A, Gosavi AS, Shirwadkar UP, et al. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics[J]. Oral Oncol, 2021, 121: 105451. doi:10.1016/j.oraloncology.2021.105451
[5]	Matson V, Chervin CS, Gajewski TF. Cancer and the microbiome-influence of the commensal microbiota on cancer, immune responses, and immunotherapy[J]. Gastroenterology, 2021, 160(2): 600-613. doi:10.1053/j.gastro.2020.11.041
[6]	Platini H, Ferdinand E, Kohar K, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers for advanced non-small-cell lung cancer treated with immunotherapy: a systematic review and meta-analysis[J]. Medicina, 2022, 58(8): 1069. doi:10.3390/medicina58081069
[7]	黄选兆, 汪吉宝, 孔维佳, 等. 实用耳鼻咽喉头颈外科学[M]. 北京: 人民卫生出版社, 2008: 488-493
[8]	王士贞. 中医耳鼻咽喉科学[M]. 北京: 中国中医药出版社, 2017: 169-172, 198-199, 202-204
[9]	Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA A Cancer J Clinicians, 2023, 73(1): 17-48. doi:10.3322/caac.21763
[10]	赵鹏, 张淑君. 有关喉癌诊断的研究进展[J]. 承德医学院学报, 2023, 40(2): 156-159. doi: 10.15921/j.cnki.cyxb.2023.02.004
[11]	张鑫婷, 汪迪, 曹萍, 等. 术前全血炎症标志物预测喉鳞状细胞癌患者预后的价值[J]. 中国眼耳鼻喉科杂志, 2022, 22(2): 131-136. doi: 10.14166/j.issn.1671-2420.2022.02.006 ZHANG Xinting, WANG Di, CAO Ping, et al. Prognostic value of whole blood inflammatory markers for patients with laryngeal squamous cell cancer undergoing surgery[J]. Chinese Journal of Ophthalmology and Otorhinolaryngology, 2022, 22(2): 131-136. doi: 10.14166/j.issn.1671-2420.2022.02.006
[12]	崔静, 张倩. 中国喉癌发病与死亡趋势分析及预测[J]. 疾病监测, 2023, 38(8): 1000-1006. doi:10.3784/jbjc.202209150406 CUI Jing, ZHANG Qian. Analysis and prediction of incidence and mortality trends of laryngeal cancer in China[J]. Disease Surveillance, 2023, 38(8): 1000-1006. doi:10.3784/jbjc.202209150406
[13]	陈斐琳, 桂意华, 黄琦. 结合术前中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值构建喉恶性肿瘤进展风险的列线图模型[J]. 中国耳鼻咽喉头颈外科, 2023, 30(9): 595-598. doi:10.16066/j.1672-7002.2023.09.011
[14]	Rumgay H, Murphy N, Ferrari P, et al. Alcohol and cancer: epidemiology and biological mechanisms[J]. Nutrients, 2021, 13(9): 3173. doi:10.3390/nu13093173
[15]	陈海棠, 何海珍. 炎症指标预测宫颈癌淋巴结转移的列线图风险模型建立与验证[J]. 中国计划生育学杂志, 2023, 31(9): 2224-2228. doi: 10.3969/j.issn.1004-8189.2023.09.044 CHEN Haitang, HE Haizhen. Establishment and verification of a nomogram model based on the inflammatory indicators of patients with cervical cancer for predicting the risk of their lymph node metastasis[J]. Chinese Journal of Family Planning, 2023, 31(9): 2224-2228. doi: 10.3969/j.issn.1004-8189.2023.09.044
[16]	吴莹, 李媛, 王晓燕. 血府逐瘀汤联合西医化疗对气滞血瘀证晚期子宫颈癌患者近期疗效及生存期的影响[J]. 中外医学研究, 2024, 22(20): 139-142. doi: 10.14033/j.cnki.cfmr.2024.20.035 WU Ying, LI Yuan, WANG Xiaoyan. Effect of xuefu zhuyu decoction combined with western chemotherapy on the short-term curative effect and survival time of advanced cervical cancer patients with qi-stagnation and blood-stasis syndrome[J]. Chinese And Foreign Medical Research, 2024, 22(20): 139-142. doi: 10.14033/j.cnki.cfmr.2024.20.035
[17]	SU Zhuoyi, ZHANG Shuai, YU Ziqiao, et al. Efficacy and safety of blood-activating herbs combined with edaravone in the treatment of acute ischemic stroke: a protocol for systematic review and meta-analysis[J]. Medicine, 2022, 101(48): 32162. doi:10.1097/MD.0000000000032162
[18]	Wu SQ, Sun Z, Guo ZH, et al. The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines(BAST)in lung cancer progression-a comprehensive review[J]. J Ethnopharmacol, 2023, 314: 116565. doi:10.1016/j.jep.2023.116565
[19]	袁见, 朱莹杰. 活血化瘀中药治疗前列腺癌的机制及用药研究进展[J]. 辽宁中医药大学学报, 2024, 26(10): 216-220. doi: 10.13194/j.issn.1673-842x.2024.10.042 YUAN Jian, ZHU Yingjie. Research progress of activating blood and dissolving stasis TCM in the treatment of prostate cancer[J].Journal of Liaoning University of Traditional Chinese Medicine, 2024, 26(10): 216-220. doi: 10.13194/j.issn.1673-842x.2024.10.042
[20]	Wang XZ, Su PW, Hao Q, et al. A Chinese classical prescription Guizhi-Fuling Wan in treatment of ovarian cancer: an overview[J]. Biomed Pharmacother, 2022, 153: 113401. doi:10.1016/j.biopha.2022.113401
[21]	Tiper IV, Temkin SM, Spiegel S, et al. VEGF potentiates GD3-mediated immunosuppression by human ovarian cancer cells[J]. Clin Cancer Res, 2016, 22(16): 4249-4258. doi:10.1158/1078-0432.CCR-15-251
[22]	Wu Q, Yu X, Li JJ, et al. Metabolic regulation in the immune response to cancer[J]. Cancer Commun, 2021, 41(8): 661-694. doi:10.1002/cac2.12182
[23]	马苏苏, 高劲, 杜炎远, 等. 基于肿瘤微环境力学应答-免疫调控论“虚郁致癌” 病机观[J]. 世界中医药, 2024, 19(15): 2290-2293. doi:10.3969/j.issn.1673-7202.2024.15.012 MA Susu, GAO Jin, DU Yanyuan, et al. Pathogenesis of deficiency and depression causing cancer based on mechanical response-immune regulation of tumor microenvironment[J]. World Chinese Medicine, 2024, 19(15): 2290-2293. doi:10.3969/j.issn.1673-7202.2024.15.012
[24]	Zhou HY, Wang M, Zhang YX, et al. Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis[J]. Cancer Commun, 2022, 42(5): 374-400. doi:10.1002/cac2.12294
[25]	程海波, 周仲瑛. 癌毒病机科学内涵的现代诠释[J].南京中医药大学学报, 2021, 37(5): 637-641. doi:10.14148/i.issn.1672-0482.2021.0637 CHENG Haibo, ZHOU Zhongying. Modern interpretation of the scientific connotation of pathogenesis of cancerous toxin[J]. J Nanjing Univ Tradit Chin Med, 2021,37(5): 637-641. doi:10.14148/i.issn.1672-0482.2021.0637
[26]	Xun YF, Wang MH, Sun HY, et al. Prognostic analysis of preoperative inflammatory biomarkers in patients with laryngeal squamous cell carcinoma[J]. Ear Nose Throat J, 2020, 99(6): 371-378. doi:10.1177/0145561319876910
[27]	马静远, 武天义, 孙占伟, 等. 鼻腔鼻窦内翻性乳头状瘤与外周血炎症标志物的相关性研究[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 35-39. doi:10.6040/j.issn.1673-3770.0.2021.264 MA Jingyuan, WU Tianyi, SUN Zhanwei, et al. Correlation between sinonasal inverted Papilloma and peripheral inflammatory blood markers[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 35-39. doi:10.6040/j.issn.1673-3770.0.2021.264
[28]	张竹萍, 叶琪, 郭蓓, 等. 叶酸受体阳性循环肿瘤细胞检测在喉鳞状细胞癌诊断中的应用价值[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 50-53. doi:10.6040/j.issn.1673-3770.0.2022.433 ZHANG Zhuping, YE Qi, GUO Bei, et al. Diagnostic utility of folate receptor-positive circulating tumor cells in patients with laryngeal squamous cell carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 50-53. doi:10.6040/j.issn.1673-3770.0.2022.433
[29]	鞠叶, 秦世成, 孙月, 等. 微RNA-509-3p/干扰素刺激基因15轴对喉癌细胞血管生成及血管内皮生长因子蛋白表达的影响[J]. 安徽医药, 2024, 28(8): 1593-1598. doi:10.3969/j.issn.1009-6469.2024.08.023 JU Ye, QIN Shicheng, SUN Yue, et al. Effects of microRNA-509-3P/interferon stimulating gene 15 axis on angiogenesis and expression of vascular endothelial growth factor protein in laryngeal cancer cells[J]. China Industrial Economics,2024, 28(8): 1593-1598. doi: 10.3969/j.issn.1009-6469.2024.08.023
[30]	张子梓, 程慧娟, 郭改改. MTA2、SET8蛋白在喉癌中的表达及与临床病理特征的关系[J]. 实用癌症杂志, 2024, 39(5): 705-709. doi: 10.3969/i.issn.1001-5930.2024.05.003 ZHANG Zizi, CHENG Huijuan, GUO Gaigai. The expression of MTA2 and SET8 proteins in laryngeal carcinoma and their relationship with clinicopathologic features[J]. The Practical Journal of Cancer, 2024, 39(5): 705-709. doi: 10.3969/i.issn.1001-5930.2024.05.003
[31]	王留珍, 王益玲, 冯海燕. MMP-2和MMP-9及胃蛋白酶对喉鳞状细胞癌侵袭作用的机制研究[J]. 中国耳鼻咽喉颅底外科杂志, 2022, 28(5): 50-55. doi: 10.11798/i.issn.1007-1520.202222237 WANG Liuzhen, WANG Yiling, FENG Haiyan. Mechanism of MMP-2, MMP-9 and pepsin on the invasion of laryngeal squamous cell carcinoma[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2022, 28(5): 50-55. doi: 10.11798/i.issn.1007-1520.202222237

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed